BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1442257)

  • 1. Lysosomal degradation of heparin and heparan sulphate.
    Freeman C; Hopwood J
    Adv Exp Med Biol; 1992; 313():121-34. PubMed ID: 1442257
    [No Abstract]   [Full Text] [Related]  

  • 2. New pathway of heparan sulphate degradation. Iduronate sulphatase and N-sulphoglucosamine 6-sulphatase act on the polymer chain prior to depolymerisation by a N-sulpho-glucosaminidase and glycuronidases in the mollusc Tagelus gibbus.
    Medeiros MG; Ferreira TM; Leite EL; Toma L; Dietrich CP; Nader HB
    Comp Biochem Physiol B Biochem Mol Biol; 1998 Mar; 119(3):539-47. PubMed ID: 9734337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence analysis of heparan sulphate and heparin oligosaccharides.
    Vivès RR; Pye DA; Salmivirta M; Hopwood JJ; Lindahl U; Gallagher JT
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):767-73. PubMed ID: 10215618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-L-iduronidase, beta-D-glucuronidase, and 2-sulfo-L-iduronate 2-sulfatase: preparation and characterization of radioactive substrates from heparin.
    Hopwood JJ
    Carbohydr Res; 1979 Mar; 69():203-16. PubMed ID: 106967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective depolymerisation of dermatan sulfate: production of radiolabelled substrates for alpha-L-iduronidase, sulfoiduronate sulfatase, and beta-D-glucuronidase.
    Hopwood JJ; Muller VJ
    Carbohydr Res; 1983 Oct; 122(2):227-39. PubMed ID: 6423280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human alpha-L-iduronidase. Catalytic properties and an integrated role in the lysosomal degradation of heparan sulphate.
    Freeman C; Hopwood JJ
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):899-908. PubMed ID: 1554373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heparin/heparan sulfate 2-O-sulfatase from Flavobacterium heparinum. Molecular cloning, recombinant expression, and biochemical characterization.
    Myette JR; Shriver Z; Claycamp C; McLean MW; Venkataraman G; Sasisekharan R
    J Biol Chem; 2003 Apr; 278(14):12157-66. PubMed ID: 12519775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human vascular endothelial cells catabolise exogenous glycosaminoglycans by a novel route.
    Dawes J; Pepper DS
    Thromb Haemost; 1992 Apr; 67(4):468-72. PubMed ID: 1378652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A glucosamine O,N-disulfate O-sulfohydrolase with a probable role in mammalian catabolism of heparan sulfate.
    Weissmann B; Chao H; Chow P
    Biochem Biophys Res Commun; 1980 Nov; 97(2):827-33. PubMed ID: 6451222
    [No Abstract]   [Full Text] [Related]  

  • 10. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor.
    Maccarana M; Casu B; Lindahl U
    J Biol Chem; 1994 Feb; 269(5):3903. PubMed ID: 8106436
    [No Abstract]   [Full Text] [Related]  

  • 11. Heparan sulphate: a heparin in miniature.
    Gallagher JT
    Handb Exp Pharmacol; 2012; (207):347-60. PubMed ID: 22566232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of heparan sulphate oligosaccharides and their degradation by exo-enzymes.
    Linker A
    Biochem J; 1979 Dec; 183(3):711-20. PubMed ID: 161508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of heparan sulfate tetrasaccharide as a substrate for human heparanase.
    Takeda N; Ikeda-Matsumi R; Ebara-Nagahara K; Otaki-Nanjo M; Taniguchi-Morita K; Nanjo M; Tamura J
    Carbohydr Res; 2012 May; 353():13-21. PubMed ID: 22486828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human liver iduronate-2-sulphatase. Purification, characterization and catalytic properties.
    Bielicki J; Freeman C; Clements PR; Hopwood JJ
    Biochem J; 1990 Oct; 271(1):75-86. PubMed ID: 2222422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substrate specificity of heparanases from human hepatoma and platelets.
    Pikas DS; Li JP; Vlodavsky I; Lindahl U
    J Biol Chem; 1998 Jul; 273(30):18770-7. PubMed ID: 9668050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-faceted substrate specificity of heparanase.
    Peterson SB; Liu J
    Matrix Biol; 2013 Jun; 32(5):223-7. PubMed ID: 23499529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential degradation of chondroitin sulfate in molluscs. Desulfation of chondroitin sulfate without prior depolymerization by a novel sulfatase from Anomalocardia brasiliana.
    de Sousa Júnior JF; Nader HB; Dietrich CP
    J Biol Chem; 1990 Nov; 265(33):20150-5. PubMed ID: 2122969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of interferon-gamma to heparan sulfate is restricted to the heparin-like domains and involves carboxylic--but not N-sulfated--groups.
    Lortat-Jacob H; Grimaud JA
    Biochim Biophys Acta; 1992 Sep; 1117(2):126-30. PubMed ID: 1525174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary storage of dermatan sulfate in Sanfilippo disease.
    Lamanna WC; Lawrence R; Sarrazin S; Esko JD
    J Biol Chem; 2011 Mar; 286(9):6955-62. PubMed ID: 21193389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate: stoichiometry, stabilization, and kinetics.
    Lookene A; Chevreuil O; Ostergaard P; Olivecrona G
    Biochemistry; 1996 Sep; 35(37):12155-63. PubMed ID: 8810923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.